4 stories mentioning LGND
Every FINWIRES story that references LGND, newest first.
Andrew Reardon, Chief Legal Officer & Secretary, on June 01, 2026, sold 5,000 shares in Ligand Pharmaceuticals (LGND) for $1,135,316. Following the Form 4 filing with the SEC, Reardon has control over a total of 41,382 common shares of the company, with 41,382 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/886163/000200101126000083/xslF345X05/edgardoc.xml
John W Kozarich, Director, on May 01, 2026, sold 2,501 shares in Ligand Pharmaceuticals (LGND) for $563,080. Following the Form 4 filing with the SEC, Kozarich has control over a total of 41,786 common shares of the company, with 41,786 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/886163/000200101126000049/xslF345X05/edgardoc.xml
Ligand Pharmaceuticals (LGND) has an average rating of buy and mean price target of $257.44 according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $218.14, Change: $+7.81, Percent Change: +3.71%
Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.